Skip to main content

Table 2 Anthropometry and blood lipid, glucose, nitrate, and creatine characteristics of Study 2 participants

From: Acute and chronic safety and efficacy of dose dependent creatine nitrate supplementation and exercise performance

  

Day

  

Variable

Group

Baseline

7

28

 

p-level

Body Weight

PLA

77.3 ± 11.9

77.6 ± 12.1

77.4 ± 12.7

Group

0.003

(kg)

CrM

81.7 ± 13.2

82.4 ± 13.4

82.6 ± 14.0

Time

0.002

 

CrN-Low

72.0 ± 9.7

72.2 ± 9.9

72.7 ± 10.0

Group × Time

0.29

 

CrN-High

90.8 ± 13.4

90.8 ± 13.2

92.0 ± 14.3

  

Fat Mass

PLA

12.7 ± 6.3

12.6 ± 6.3

12.7 ± 6.3

Group

0.02

(kg)

CrM

12.9 ± 5.3

13.0 ± 5.5

13.2 ± 5.2

Time

0.17

 

CrN-Low

8.9 ± 4.7

8.7 ± 4.6

9.1 ± 4.7

Group × Time

0.90

 

CrN-High

16.5 ± 6.9

16.2 ± 6.4

16.6 ± 7.4

  

Fat-Free Mass

PLA

58.1 ± 8.0

58.5 ± 8.0

58.3 ± 8.3

Group

0.01

(kg)

CrM

62.4 ± 8.7

62.5 ± 8.8

62.9 ± 9.2

Time

0.02

 

CrN-Low

56.9 ± 7.4

57.4 ± 7.3

57.3 ± 7.3

Group × Time

0.50

 

CrN-High

67.4 ± 8.1

67.7 ± 8.2

68.5 ± 8.2

  

Body Fat

PLA

17.8 ± 6.9

17.1 ± 6.7

17.2 ± 6.7

Group

0.07

(%)

CrM

16.7 ± 4.0

16.8 ± 4.3

16.8 ± 3.7

Time

0.24

 

CrN-Low

13.1 ± 5.4

12.8 ± 5.2

13.2 ± 5.2

Group × Time

0.78

 

CrN-High

19.2 ± 5.9

18.7 ± 5.5

18.8 ± 6.3

  

Total Body Water

PLA

51.3 ± 4.5

50.6 ± 5.1

52.5 ± 6.9

Group

0.18

(%)

CrM

51.4 ± 3.3

50.8 ± 3.7

49.4 ± 8.4

Time

0.64

 

CrN-Low

52.9 ± 4.6

54.1 ± 5.1

52.7 ± 4.2

Group × Time

0.47

 

CrN-High

50.6 ± 6.5

48.8 ± 4.1

49.0 ± 4.7

  

Lipids, Glucose, Nitrate, and Creatine

  

 Total-C

PLA

165.0 ± 33.4

161.5 ± 38.8

164.6 ± 38.8

Group

0.19

 (mg/dl)

CrM

174.4 ± 25.5

175.4 ± 27.8

183.4 ± 41.1

Time

0.38

 

CrN-Low

151.9 ± 35.8

149.7 ± 29.5

150.0 ± 37.5

Group × Time

0.83

 

CrN-High

162.7 ± 25.1

155.9 ± 23.8

160.7 ± 29.1

  

 HDL-C

PLA

49.2 ± 11.4

50.6 ± 10.2

50.3 ± 12.8

Group

0.62

 (mg/dl)

CrM

51.8 ± 15.2

54.7 ± 15.5

55.2 ± 17.4

Time

0.36

 

CrN-Low

48.6 ± 15.7

48.3 ± 15.1

47.9 ± 12.8

Group × Time

0.85

 

CrN-High

46.7 ± 10.7

47.2 ± 12.3

48.7 ± 10.6

  

 Total-C/HDL-C

PL

3.45 ± 0.71

3.23 ± 0.64

3.30 ± 0.59

Group

0.82

 Ratio

CrM

3.70 ± 1.46

3.50 ± 1.34

3.69 ± 1.58

Time

0.24

 (mg/dl)

CrN-Low

3.26 ± 0.81

3.32 ± 1.04

3.29 ± 1.05

Group × Time

0.74

 

CrN-High

3.62 ± 0.82

3.47 ± 0.88

3.44 ± 0.94

  

 LDL-C

PLA

93.4 ± 23.4

91.7 ± 29.6

95.8 ± 34.6

Group

0.34

 (mg/dl)

CrM

103.8 ± 33.3

106.6 ± 33.5

112.2 ± 49.0

Time

0.36

 

CrN-Low

86.3 ± 22.6

84.8 ± 23.7

87.3 ± 28.7

Group × Time

0.88

 

CrN-High

95.2 ± 25.0

93.4 ± 22.9

94.3 ± 28.4

  

 Triglyceride

PLA

109.1 ± 52.5

98.2 ± 36.9

94.2 ± 19.1

Group

0.63

 (mg/dl)

CrM

114.5 ± 60.6

93.1 ± 30.9

112.0 ± 42.6

Time

0.16

 

CrN-Low

87.5 ± 43.2

90.7 ± 49.1

85.8 ± 30.7

Group × Time

0.69

 

CrN-High

104.8 ± 47.1

85.6 ± 39.2

97.2 ± 49.8

  

 Glucose

PLA

102.0 ± 18.6

102.1 ± 15.3

94.9 ± 12.6

Group

0.74

 (mg/dl)

CrM

97.5 ± 13.9

99.7 ± 15.1

100.4 ± 16.8

Time

0.70

 

CrN-Low

96.1 ± 8.5

96.1 ± 7.9

96.4 ± 17.9

Group × Time

0.27

 

CrN-High

97.1 ± 9.4

93.2 ± 5.2

96.0 ± 9.4

  

 Nitrate

PLA

4.5 ± 2.0

5.1 ± 3.3

9.0 ± 15.3

Group

0.001

 (μmol/L)

CrM

4.9 ± 3.6

3.8 ± 1.8

4.5 ± 1.8

Time

0.001

 

CrN-Low

5.6 ± 3.1

64.8 ± 30.9a,b

13.9 ± 13.9

Group × Time

0.001

 

CrN-High

4.3 ± 1.6

72.0 ± 47.3a,b

21.5 ± 28.9b

  

 Creatine

PLA

131.1 ± 92.2

143.5 ± 131.9

150.6 ± 152.0

Group

0.04

 (μmol/L)

CrM

165.2 ± 94.4c

504.9 ± 422.8d

231.2 ± 126.1

Time

0.001

 

CrN-Low

73.0 ± 56.4

170.4 ± 153.7

147.9 ± 95.3

Group × Time

0.01

 

CrN-High

120.3 ± 99.8

241.3 ± 131.9

251.9 ± 406.4

  
  1. Data are mean ± SD. To convert respective values to mmol/L multiply total cholesterol, HDL-C and LDL-C multiply by 0.0259; triglycerides by 0.0113, BUN by 0.357 and glucose by 0.0555. To convert creatinine to μmol/L multiply by 88.54. p < 0.05 considered significant
  2. Statistical notations. adenotes a significant difference from PLA. bdenotes a significant difference from CrM. cdenotes a significant difference from CrN-Low. ddenotes a significant difference from PLA, CrN-Low, and CrN-High